NO982265L - Diagnostikk for og mediatorer for inflammatoriske forstyrrelser - Google Patents

Diagnostikk for og mediatorer for inflammatoriske forstyrrelser

Info

Publication number
NO982265L
NO982265L NO982265A NO982265A NO982265L NO 982265 L NO982265 L NO 982265L NO 982265 A NO982265 A NO 982265A NO 982265 A NO982265 A NO 982265A NO 982265 L NO982265 L NO 982265L
Authority
NO
Norway
Prior art keywords
host
mediators
diagnosis
kit
inflammatory disorders
Prior art date
Application number
NO982265A
Other languages
English (en)
Other versions
NO982265D0 (no
Inventor
Sampath Parthasarathy
Russel M Medford
Wayne R Alexander
Original Assignee
Atherogenics Inc
Univ Emory
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Atherogenics Inc, Univ Emory filed Critical Atherogenics Inc
Publication of NO982265D0 publication Critical patent/NO982265D0/no
Publication of NO982265L publication Critical patent/NO982265L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

En fremgangsmåte for et sett for diagnostisering og kvantifisering av oksidasjonstilstanden, og spesifikt, nivå av lipid peroksidasjon, til en vert er tilveiebrakt og innbefatter kontakting av vertens biologiske prøve med et antistoff mot et antigen dannet ved omsetning av et lipidhydroperoksid med et primært amin. Denne fremgangsmåten vurderer risiko for, eller eksistensen av, oksidativ skade i verten. Det er også beskrevet monoklonale og polyklonale antistoffer, samt antistoff-fragmenter, eventuelt i renset eller isolert form, som er nyttige i denne fremgangsmåten og dette settet.
NO982265A 1996-09-20 1998-05-18 Diagnostikk for og mediatorer for inflammatoriske forstyrrelser NO982265L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2640196P 1996-09-20 1996-09-20
US3933397P 1997-03-17 1997-03-17
PCT/US1997/016695 WO1998012561A1 (en) 1996-09-20 1997-09-19 Diagnostics for and mediators of inflammatory disorders

Publications (2)

Publication Number Publication Date
NO982265D0 NO982265D0 (no) 1998-05-18
NO982265L true NO982265L (no) 1998-07-16

Family

ID=26701197

Family Applications (1)

Application Number Title Priority Date Filing Date
NO982265A NO982265L (no) 1996-09-20 1998-05-18 Diagnostikk for og mediatorer for inflammatoriske forstyrrelser

Country Status (16)

Country Link
US (1) US20020052000A1 (no)
EP (1) EP0883811A1 (no)
JP (1) JP2000500879A (no)
KR (1) KR19990071477A (no)
AU (1) AU722625B2 (no)
BG (1) BG102541A (no)
BR (1) BR9710402A (no)
CA (1) CA2237191A1 (no)
CZ (1) CZ146598A3 (no)
EA (1) EA002520B1 (no)
HU (1) HUP0102907A1 (no)
NO (1) NO982265L (no)
NZ (1) NZ330475A (no)
PL (1) PL326750A1 (no)
SK (1) SK66198A3 (no)
WO (1) WO1998012561A1 (no)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6225070B1 (en) 1997-08-07 2001-05-01 The Regents Of The University Of California Antibodies to oxidation-specific epitopes on lipoprotein and methods for their use in detecting, monitoring and inhibiting the growth of atheroma
US6919076B1 (en) 1998-01-20 2005-07-19 Pericor Science, Inc. Conjugates of agents and transglutaminase substrate linking molecules
US6958148B1 (en) 1998-01-20 2005-10-25 Pericor Science, Inc. Linkage of agents to body tissue using microparticles and transglutaminase
CA2348685A1 (en) * 1998-11-06 2000-05-18 Emory University Biomarkers for oxidative stress
US6953666B1 (en) 1998-11-06 2005-10-11 Emory University Biomarkers for oxidative stress
JP4629175B2 (ja) * 1999-12-16 2011-02-09 日油株式会社 モノクローナル抗体
US6495335B2 (en) * 2000-12-07 2002-12-17 Mario Chojkier Compositions and methods for diagnosing alzheimer's disease
US20040253637A1 (en) * 2001-04-13 2004-12-16 Biosite Incorporated Markers for differential diagnosis and methods of use thereof
US7713705B2 (en) * 2002-12-24 2010-05-11 Biosite, Inc. Markers for differential diagnosis and methods of use thereof
US20040126767A1 (en) * 2002-12-27 2004-07-01 Biosite Incorporated Method and system for disease detection using marker combinations
US20040203083A1 (en) * 2001-04-13 2004-10-14 Biosite, Inc. Use of thrombus precursor protein and monocyte chemoattractant protein as diagnostic and prognostic indicators in vascular diseases
WO2003016910A1 (en) * 2001-08-20 2003-02-27 Biosite, Inc. Diagnostic markers of stroke and cerebral injury and methods of use thereof
US20030199000A1 (en) * 2001-08-20 2003-10-23 Valkirs Gunars E. Diagnostic markers of stroke and cerebral injury and methods of use thereof
US20040121350A1 (en) * 2002-12-24 2004-06-24 Biosite Incorporated System and method for identifying a panel of indicators
US20040209307A1 (en) * 2001-08-20 2004-10-21 Biosite Incorporated Diagnostic markers of stroke and cerebral injury and methods of use thereof
US20040219509A1 (en) * 2001-08-20 2004-11-04 Biosite, Inc. Diagnostic markers of stroke and cerebral injury and methods of use thereof
RU2235334C2 (ru) * 2002-08-12 2004-08-27 Мультановский Борис Львович Способ контроля эффективности санаторного этапа реабилитации больных инфарктом миокарда
RU2239837C2 (ru) * 2002-08-15 2004-11-10 Государственное учреждение системы высшего и послевузовского профессионального образования "Сибирский государственный медицинский университет" Способ оценки степени тяжести атопического дерматита
US7060225B2 (en) * 2003-03-20 2006-06-13 Northeastern Ohio Universities College Of Medicine Self-contained assay device for rapid detection of biohazardous agents
CN101043884A (zh) * 2004-07-01 2007-09-26 谢彭斯眼科研究公司 用于治疗眼部疾病和病症的组合物和方法
US20070265341A1 (en) * 2004-07-01 2007-11-15 The Schepens Eye Research Institute Inc. Compositions and methods for treating eye disorders and conditions
US8129123B2 (en) 2004-10-05 2012-03-06 The Regents Of The University Of California Methods for assessing atherogenesis by determining oxidized phospholipid to apolipoprotein B ratios
KR101230740B1 (ko) * 2010-09-08 2013-02-07 인제대학교 산학협력단 자간전증의 조기 진단 및 예후 평가 방법
US10017453B2 (en) * 2013-11-15 2018-07-10 Ds Biopharma Limited Pharmaceutically acceptable salts of fatty acids
ES2955883T3 (es) 2015-06-19 2023-12-07 Sera Prognostics Inc Pares de biomarcadores para la predicción del parto prematuro
AU2018317902B2 (en) 2017-08-18 2025-02-20 Sera Prognostics, Inc. Pregnancy clock proteins for predicting due date and time to birth
US20210315851A1 (en) 2020-04-03 2021-10-14 Afimmune Limited Compositions comprising 15-hepe and methods of treating or preventing hematologic disorders, and/or related diseases

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675281A (en) * 1984-07-09 1987-06-23 Lands William E M Quantification of hydroperoxides using prostaglandin H synthase
US5380747A (en) * 1992-10-30 1995-01-10 Emory University Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
US5807884A (en) * 1992-10-30 1998-09-15 Emory University Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
EP0658205B1 (en) * 1993-06-25 2000-03-15 Smithkline Beecham Plc Lipoprotein associated phospholipase a2, inhibitors thereof and use of the same in diagnosis and therapy
WO1997015599A1 (en) * 1995-10-27 1997-05-01 Board Of Regents Of The University Of Nebraska Novel acetaldehyde and malondialdehyde protein adducts as markers for alcohol liver disease

Also Published As

Publication number Publication date
AU722625B2 (en) 2000-08-10
WO1998012561A1 (en) 1998-03-26
PL326750A1 (en) 1998-10-26
HUP0102907A1 (hu) 2004-05-28
EP0883811A1 (en) 1998-12-16
CZ146598A3 (cs) 1998-11-11
AU4647397A (en) 1998-04-14
EA002520B1 (ru) 2002-06-27
KR19990071477A (ko) 1999-09-27
BG102541A (en) 1999-02-26
CA2237191A1 (en) 1998-03-26
JP2000500879A (ja) 2000-01-25
BR9710402A (pt) 1999-08-17
SK66198A3 (en) 1999-09-10
NO982265D0 (no) 1998-05-18
US20020052000A1 (en) 2002-05-02
NZ330475A (en) 1999-11-29
EA199800460A1 (ru) 1998-12-24

Similar Documents

Publication Publication Date Title
EA199800460A1 (ru) Диагностика и медиаторы воспалительных нарушений
NO331148B1 (no) Anvendelse av et monoklonalt eller polyklonalt antistoff, samt fremgangsmate og kit for in vitro diagnose.
ES2094733T3 (es) Deteccion de enfermedades o disfunciones neurologicas.
NO20006681D0 (no) Fremgangsmåte ved tidlig diagnose av karsinomer
DK0677533T3 (da) Antistoffer mod epitoper med homologi til selv-antigener, fremgangsmåder til fremstilling og anvendelser deraf
ATE114672T1 (de) Peptidzusammensetzung und verfahren zum nachweis von antikörpern gegen htlv-iii.
AU7652194A (en) A method of assaying collagen fragments in body fluids, a test kit and means for carrying out the method and use of the method to diagnose the presence of disorders associated with the metabolism of collagen
ATE245699T1 (de) Rekombinant pgp3, verfahren zu dessen herstellung,und dessen verwendung in der diagnose und therapie
ES2138102T3 (es) Procedimiento para la deteccion de antigeno urinario asociado a tumores.
NO964015L (no) Fremgangsmåte for påvisning av kalpain-aktivering og identifisering av kalpain-inhibitorer
ATE74662T1 (de) Immunoanalysetestverfahren fuer cholesterolepoxide.
NO950325L (no) Immunanalyse for påvisning av kollagen eller kollagenfragmenter
EP0230934A3 (en) Monoclonal antibody, measuring method of glucosylated protein by utilizing the monoclonal antibody, and kit therefor.
EP0585960A3 (en) Diagnostic method for autoimmune diseases
ATE44621T1 (de) Proteinkonjugate von penicillosaeure, ihre herstellung und verwendung.
BR9100924A (pt) Linha de celulas de hibridoma,mutantes,anticorpos,processo para a preparacao de uma linha de celulas de hibridoma,processo para a preparacao de anticorpos,processo e agente para a prova imunologica de metolacloro,derivado de metolacloro e processo para sua preparacao
PL366996A1 (en) Method and means for detecting gluten-induced diseases
AU2001274239A1 (en) Neurotransmission disorders
EP0364971A3 (en) Process for the detection of legionella antigens in body fluids and the like, as well as a test kit for performing the process
NO852058L (no) Fremgangsmaate og middel for bestemmelse av atl virus antistoffer.
DE69939742D1 (de) Antikörper gegen intrazelluläre domänen der protein tyrosin phosphatase
CA2286335A1 (en) Methods of obtaining antigens specific for fungi, antibodies for such antigens, and diagnosis of disease using such antigens and/or antibodies
ATE110470T1 (de) Immuntestverfahren von chondrocalcin.
ES2160783T3 (es) Metodos para detectar parvovirus humano.
AU2562088A (en) Detection of tumor-associated markers in biological fluids

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application